New model of atherosclerosis in insulin resistant sand rats: Hypercholesterolemia combined with D2 vitamin

Atherosclerosis

Volumn 150, Issue 1, 2000, Pages 55-61

  Bennani Kabchi, N ^a   Kehel, L ^a   El Bouayadi, F ^a   Fdhil, H ^a   Amarti, A ^b   Saidi, A ^b   Marquie G ^c  

^a MOHAMMED V UNIVERSITY   (Morocco)

^b IBN SINA HOSPITAL   (Morocco)

^c CHU RANGUEIL   (France)

Author keywords

Atherosclerosis; D2 vitamin; Hypercholesterolemia; Insulin resistance; Sand rat

Indexed keywords

CALCIUM; ERGOCALCIFEROL; INSULIN; LIPID;

ANIMAL; AORTA; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CHOLESTEROL INTAKE; DISEASE MODEL; FEMALE; GERBIL; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; MALE; METABOLISM; PATHOLOGY;

ANIMALS; AORTA; ARTERIOSCLEROSIS; BLOOD GLUCOSE; CALCIUM; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; ERGOCALCIFEROLS; FEMALE; GERBILLINAE; HYPERCHOLESTEROLEMIA; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MYOCARDIUM;

EID: 0034184063     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00365-2     Document Type: Article

References (23)

1. Marquié G, Duhault J, Hadjiisky P, Petkov P, Bouissou H. Diabetes mellitus in sand rats (Psammomys obesus): microangiopathy during development of the diabetic syndrome. Cell Mol Biol 1991;37(6):651-67.
2. Marquié G, Hadjiisky P, Arnaud O, Duhault J. Development of macroangiopathy in sand rats (Psammomys obesus), an animal model of non-insulin-dependent diabetes mellitus: effect of gliclazide. Am J Med 1991;90(6A):55-61.
3. Marquié G, El Madani T, Solera ML, Pieraggi MT, Hadjiisky P, Ravel D, Seguin L, Bennani N. Metabolic and anti-atherogenic effects of long-term benfluorex in dyslipidemic insulin-resistant sand rats (Psammomys obesus). Life Sci 1998;63:65-76.
4. Caplice NM, Fennessy PA, Manderson JA, Campbell GR, Campbell JH. Rabbit models of atherosclerosis and restenosis. In: Woodford FP, Davignon J, Sniderman A, editors. Atherosclerosis X. Amsterdam: Elsevier, 1995:114-20.
5. Hadjiisky P, Renais J, Scebat L. Myocyte aortique et calcification artérielle calciférolique. Etude ultrastructurale et histochimique. Par Art 1981;4(2):111-33.
6. Alcindor LG, Antebi H, Halpern MJ, editors. Molecular Biology of Atherosclerosis. J Libbey and Company, London: 1992:383-388.
7. Stokke KT, Norum KR. Scand J Clin Lab Invest 1971;17:21-7.
8. Steinberg D, Pearson TA, Kuller LH. Alcohol and atherosclerosis. Ann Intern Med 1991;114:967-76.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
10. Fruchart JC. Le transport du cholestérol et sa fixation dans les artères, Pour la Science 1992:175.
11. Gerrity RG, Antonov AS, Munn DH, Bell FP, Virmani R, Kolodgie F. The macrophage in human and experimental atherosclerosis. In: Woodford FP, Davignon J, Sniderman A, editors. Atherosclerosis X. Amsterdam: Elsevier, 1995:577-81.
12. Steinberg D, Witztum JL. Lipoproteins and atherogenesis. Current concepts. J Am Med Assoc 1990;264:3047-52.
13. Ziv E, Kalman R, Hershkop K, Barash V, Shafrir E, Bar-On H. Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinaemic state. Diabetologia 1996;39:1269-75.
14. Marquié G, El Madani T, Solera ML, Duhault J, Espinal J, Khallayoun S, Bennani-Kabchi N. The S15261, novel agent for the treatment of insulin resistance. Studies on Psammomys obesus. Life Sci 1997;61(18):1741-53.
15. Stout RW. Insulin and atheroma. 20-Yr. perspective. Diabetes Care 1990;13(6):631-54.
16. Leutenegger M. Macroangiopathie diabétique, physiopathologie, implications thérapeutiques. STV 1995;7(4):247-56.
17. Stout RW. The role of insulin in atherosclerosis in diabetics and nondiabetics: a review. Diabetes 1981;30(2):54-7.
18. Yamanouchi J, Sugawara Y, Itagaki S, Doi K Ultrastructure of atheromatous lesions experimentally induced in Syrian hamsters of the APA strain. Histol Histopathol 1997;12(2):433-8.
19. Magnaghi A, Giannini SD, Sinhorini IL, Merusse JL. Behavior of the arterial wall of non-selected rats, old and young, subjected to potentially atherogenic dietary factors. Arq Bras Cardiol 1991;56(5):385-8.
20. Demer LL. Effect of calcification on in vivo mechanical response of rabbit arteries to ballon dilation. Circulation 1991;83(6):2083-93.
21. Kramsch DM. Atherosclerosis progression/regression: lipoprotein and vessel wall determinants. Atherosclerosis 1995;118:S29-36.
22. Henry PD, Bentley KI. Supression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest 1981;68:1366.
23. Weinstein DB, Heider JG. Antiatherogenic properties of calcium antagonists. Am J Cardiol 1987;59:163B.